Literature DB >> 12588871

Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability.

Alexandrine Derrien1, Bin Zheng, James L Osterhout, Yong-Chao Ma, Graeme Milligan, Marilyn G Farquhar, Kirk M Druey.   

Abstract

The amplitude of signaling evoked by stimulation of G protein-coupled receptors may be controlled in part by the GTPase accelerating activity of the regulator of G protein signaling (RGS) proteins. In turn, subcellular targeting, protein-protein interactions, or post-translational modifications such as phosphorylation may shape RGS activity and specificity. We found previously that RGS16 undergoes tyrosine phosphorylation on conserved tyrosine residues in the RGS box. Phosphorylation on Tyr(168) was mediated by the epidermal growth factor receptor (EGFR). We show here that endogenous RGS16 is phosphorylated after epidermal growth factor stimulation of MCF-7 cells. In addition, p60-Src or Lyn kinase phosphorylated recombinant RGS16 in vitro, and RGS16 underwent phosphorylation in the presence of constitutively active Src (Y529F) in EGFR(-) CHO-K1 cells. Blockade of endogenous Src activity by selective inhibitors attenuated RGS16 phosphorylation induced by pervanadate or receptor stimulation. Furthermore, the rate of RGS16 degradation was reduced in cells expressing active Src or treated with pervanadate or a G protein-coupled receptor ligand (CXCL12). Induction of RGS16 tyrosine phosphorylation was associated with increased RGS16 protein levels and enhanced GAP activity in cell membranes. These results suggest that Src mediates RGS16 tyrosine phosphorylation, which may promote RGS16 stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588871     DOI: 10.1074/jbc.M210371200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

2.  RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression.

Authors:  Ji Hyang Kim; Jin Young Lee; Kyu Taek Lee; Jong Kyoon Lee; Kwang Hyuck Lee; Kee-Taek Jang; Jin Seok Heo; Seong Ho Choi; Jong Chul Rhee
Journal:  Tumour Biol       Date:  2010-06-23

3.  Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation.

Authors:  Zhihui Xie; Zhao Yang; Kirk M Druey
Journal:  J Mol Cell Biol       Date:  2010-10-25       Impact factor: 6.216

Review 4.  The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.

Authors:  B Sjögren
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

5.  Residue-level determinants of RGS R4 subfamily GAP activity and specificity towards the Gi subfamily.

Authors:  Ali Asli; Sabreen Higazy-Mreih; Meirav Avital-Shacham; Mickey Kosloff
Journal:  Cell Mol Life Sci       Date:  2021-07-22       Impact factor: 9.261

Review 6.  Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.

Authors:  Mohammed Alqinyah; Shelley B Hooks
Journal:  Cell Signal       Date:  2017-10-16       Impact factor: 4.315

Review 7.  Regulators of G-protein signaling in the heart and their potential as therapeutic targets.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

8.  Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.

Authors:  Ancy D Nalli; Divya P Kumar; Othman Al-Shboul; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

9.  Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts.

Authors:  Avi Raveh; Pamela J Schultz; Lauren Aschermann; Colleen Carpenter; Giselle Tamayo-Castillo; Shugeng Cao; Jon Clardy; Richard R Neubig; David H Sherman; Benita Sjögren
Journal:  Mol Pharmacol       Date:  2014-08-01       Impact factor: 4.436

10.  Molecular architecture of Galphao and the structural basis for RGS16-mediated deactivation.

Authors:  Kevin C Slep; Michele A Kercher; Thomas Wieland; Ching-Kang Chen; Melvin I Simon; Paul B Sigler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.